Basic Information
NexoBrid
Regulatory Information
EMEA/H/C/002246
December 18, 2012
September 20, 2012
16
February 1, 2024
Company Information
Germany
MediWound Germany GmbH Hans-Sachs-Strasse 100 65428 Rüsselsheim
Mediwound Germany GmbH
Active Substances Detail
proteolytic enzymes enriched in bromelain
EMA Resources
Detailed Information
Therapeutic Indication
### Therapeutic indication NexoBrid is indicated in all age groups for removal of eschar in patients with deep partial- and full-thickness thermal burns.
Overview Summary
NexoBrid is a medicine used for removing eschar (dead tissue which is dried out, thick, leathery and black) due to skin burns caused by heat or fire. It can be used both for deep partial-thickness burns (sometimes called ‘second degree’ burns) which extend into a deep region of an inner layer of the skin called the dermis, and full-thickness burns (sometimes called ‘third degree’ burns) which extend even deeper, through the whole dermis. The active substance in NexoBrid is a concentrate of proteolytic enzymes enriched in bromelain.